These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37119365)

  • 1. A structural model of the iRhom-ADAM17 sheddase complex reveals functional insights into its trafficking and activity.
    Kahveci-Türköz S; Bläsius K; Wozniak J; Rinkens C; Seifert A; Kasparek P; Ohm H; Oltzen S; Nieszporek M; Schwarz N; Babendreyer A; Preisinger C; Sedlacek R; Ludwig A; Düsterhöft S
    Cell Mol Life Sci; 2023 Apr; 80(5):135. PubMed ID: 37119365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release.
    Düsterhöft S; Kahveci-Türköz S; Wozniak J; Seifert A; Kasparek P; Ohm H; Liu S; Kopkanova J; Lokau J; Garbers C; Preisinger C; Sedlacek R; Freeman M; Ludwig A
    Cell Mol Life Sci; 2021 Jun; 78(11):5015-5040. PubMed ID: 33950315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
    Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
    Elife; 2018 Jun; 7():. PubMed ID: 29897336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status update on iRhom and ADAM17: It's still complicated.
    Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17.
    Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE.
    Oikonomidi I; Burbridge E; Cavadas M; Sullivan G; Collis B; Naegele H; Clancy D; Brezinova J; Hu T; Bileck A; Gerner C; Bolado A; von Kriegsheim A; Martin SJ; Steinberg F; Strisovsky K; Adrain C
    Elife; 2018 Jun; 7():. PubMed ID: 29897333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.
    Tang B; Li X; Maretzky T; Perez-Aguilar JM; McIlwain D; Xie Y; Zheng Y; Mak TW; Weinstein H; Blobel CP
    FASEB J; 2020 Apr; 34(4):4956-4969. PubMed ID: 32103528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth.
    Badenes M; Burbridge E; Oikonomidi I; Amin A; de Carvalho É; Kosack L; Mariano C; Domingos P; Faísca P; Adrain C
    Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36720499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I.
    Calligaris M; Spanò DP; Bonelli S; Müller SA; Carcione C; D'apolito D; Amico G; Miele M; Di Bella M; Zito G; Nuti E; Rossello A; Blobel CP; Lichtenthaler SF; Scilabra SD
    Cell Mol Life Sci; 2024 Apr; 81(1):163. PubMed ID: 38570362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.
    Maney SK; McIlwain DR; Polz R; Pandyra AA; Sundaram B; Wolff D; Ohishi K; Maretzky T; Brooke MA; Evers A; Vasudevan AA; Aghaeepour N; Scheller J; Münk C; Häussinger D; Mak TW; Nolan GP; Kelsell DP; Blobel CP; Lang KS; Lang PA
    Sci Signal; 2015 Nov; 8(401):ra109. PubMed ID: 26535007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of iRhom2 in Olfaction: Implications for Odorant Receptor Regulation and Activity-Dependent Adaptation.
    Azzopardi SA; Lu HY; Monette S; Rabinowitsch AI; Salmon JE; Matsunami H; Blobel CP
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.
    Li X; Maretzky T; Perez-Aguilar JM; Monette S; Weskamp G; Le Gall S; Beutler B; Weinstein H; Blobel CP
    J Cell Sci; 2017 Mar; 130(5):868-878. PubMed ID: 28104813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
    Al-Salihi MA; Lang PA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.
    Grieve AG; Xu H; Künzel U; Bambrough P; Sieber B; Freeman M
    Elife; 2017 Apr; 6():. PubMed ID: 28432785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
    Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
    J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
    Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
    J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
    Lu F; Zhao H; Dai Y; Wang Y; Lee CH; Freeman M
    Mol Cell; 2024 Jun; 84(11):2152-2165.e5. PubMed ID: 38781971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding.
    Maretzky T; McIlwain DR; Issuree PD; Li X; Malapeira J; Amin S; Lang PA; Mak TW; Blobel CP
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11433-8. PubMed ID: 23801765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.